v3.26.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Ordinary shares
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2025   257,211,899      
Beginning balance at Jun. 30, 2025 $ 1,817 $ 2,355 $ 89 $ (596) $ (30)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Ordinary shares – at-the-market offering, net of issuance costs (in shares)   23,041,102      
Issuance of Ordinary shares – at-the-market offering, net of issuance costs 600 $ 600      
Issuance of Ordinary shares – restricted stock units (in shares)   314,237      
Issuance of Ordinary shares – restricted stock units 2 $ 2 (29)    
Issuance of Ordinary shares – stock options (in shares)   2,309,065      
Issuance of Ordinary shares – stock options 9 $ 9      
Stock-based compensation 69   69    
Other comprehensive income (loss) (5)       (5)
Net income (loss) 385     385  
Ending balance (in shares) at Sep. 30, 2025   282,876,303      
Ending balance at Sep. 30, 2025 2,876 $ 2,966 158 (212) (36)
Beginning balance (in shares) at Jun. 30, 2025   257,211,899      
Beginning balance at Jun. 30, 2025 1,817 $ 2,355 89 (596) (30)
Ending balance (in shares) at Jun. 30, 2026   380,193,608      
Ending balance at Jun. 30, 2026 4,186 $ 7,173 (1,647) (1,299) (41)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Ordinary shares – at-the-market offering, net of issuance costs (in shares)   12,265,474      
Issuance of Ordinary shares – at-the-market offering, net of issuance costs 541 $ 541      
Issuance of Ordinary shares – restricted stock units (in shares)   1,321,196      
Issuance of Ordinary shares – restricted stock units 0 $ 29      
Issuance of Ordinary shares – stock options (in shares)   453,431      
Issuance of Ordinary shares – stock options 1 $ 1      
Issuance of Ordinary shares - Mirantis acquisition (in shares)   12,632,234      
Issuance of Ordinary shares – Mirantis acquisition 502 $ 502      
Replacement equity awards – Mirantis acquisition 24   24    
Stock-based compensation 106   106    
Other comprehensive income (loss) 19       19
Net income (loss) (263)     (263)  
Ending balance (in shares) at Sep. 30, 2026   406,865,943      
Ending balance at Sep. 30, 2026 $ 5,116 $ 8,246 $ (1,546) $ (1,562) $ (22)